Influences on viral replication and sensitivity to GLS4, a HAP compound, of naturally occurring T109/V124 mutations in hepatitis B virus core protein-Reference-Cited by-同舟云学术

Influences on viral replication and sensitivity to GLS4, a HAP compound, of naturally occurring T109/V124 mutations in hepatitis B virus core protein

Published:2017-05-23 Issue:10 Volume:89 Page:1804-1810
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J Med Virol

Author:

Wang Jianghua¹^ORCID,Zhang Haiying¹,Zhang Yingjun²,Jiang Dong³,Li Jing²,Goldmann Siegfried²,Ren Qingyun²,Fei Ran¹,Wang Xueyan¹,Wei Lai¹

Affiliation:

1. Peking University People's Hospital; Peking University Hepatology Institute; Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases; Peking University; Beijing China

2. State Key Laboratory of Anti-Infective Drug Development; Sunshine Lake Pharma Co., Ltd.; Dong Guan China

3. Institute of Infectious Diseases; Beijing Ditan Hospital; Capital Medical University; Beijing China

Funder

Natural Science Foundation of Beijing Municipality

National Natural Science Foundation of China

China National Science and Technology Major Project for Infectious Diseases Control during the 12th Five-Year Plan Period

Publisher

Wiley

Subject

Infectious Diseases,Virology

Reference19 articles.

1. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity;Ott;Vaccine,2012

2. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010;Lozano;Lancet,2012

3. Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial;Janssen;Lancet,2005

4. Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B;Lau;N Engl J Med,2005

5. Benefits and risks of nucleoside analog therapy for hepatitis B;Dienstag;Hepatology,2009

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Viral sequence analysis of chronic hepatitis B patients treated with the capsid assembly modulator JNJ-56136379 in the JADE phase 2a study;Antiviral Research;2023-08

2. The premise of capsid assembly modulators towards eliminating HBV persistence;Expert Opinion on Drug Discovery;2023-07-30

3. Preclinical characterization of ABI-H2158, an HBV core inhibitor with dual mechanisms of action;Antiviral Research;2023-01

4. Design and Synthesis of Hepatitis B Virus (HBV) Capsid Assembly Modulators and Evaluation of Their Activity in Mammalian Cell Model;Pharmaceuticals;2022-06-22

5. Direct‐Acting Antivirals for the Treatment of Chronic Hepatitis B Virus (HBV) Infection;New Drug Development for Known and Emerging Viruses;2021-12-03